Matteo Serenari1, Matteo Zanello1, Erik Schadde2, Elena Toschi1, Francesca Ratti3, Enrico Gringeri4, Michele Masetti1, Umberto Cillo4, Luca Aldrighetti3, Elio Jovine5. 1. Division of General Surgery, Maggiore Hospital, Bologna, Italy. 2. Department of Surgery, Cantonal Hospital Winterthur and Institute of Physiology, University of Zurich, Zurich, Switzerland. 3. Department of Surgery, Hepatobiliary Surgery Unit, Vita-Salute San Raffaele University, Milan, Italy. 4. General Surgery and Organ Transplantation Hepatobiliary Surgery and Liver Transplant Unit, University of Padua, Padua, Italy. 5. Division of General Surgery, Maggiore Hospital, Bologna, Italy. Electronic address: elio.jovine@ausl.bologna.it.
Abstract
BACKGROUND: Posthepatectomy liver failure is one of the most feared complications in extended hepatic resections. In 2012, a novel two-stage liver resection was developed, able to induce rapid and extensive hypertrophy by portal vein ligation and in situ liver splitting - Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS). The technique became more widely employed but its use remained controversial due to reporting of high complication and mortality rates. METHOD: A national audit was performed to gather information about the safety of the procedure and to better understand the complications. The audit was offered to all high-volume hepatobiliary centers in Italy. RESULTS: Of all Italian centers approached in January 2012, 12 centers with experience in ALPPS enrolled and participated in collection of data. Fifty patients underwent ALPPS between 2012 and 2014. In 48/50 patients completion of hepatectomy was performed successfully. Major morbidity occurred in 54% with a 20% 90-day mortality. Uni- and multivariate analysis showed that ALPPS for cholangiocarcinoma and a peak of bilirubin over 5 mg/dl between stages was associated with increase of 90-day mortality and worse survival. DISCUSSION: It is proposed that a moratorium be introduced for classic ALPPS in cholangiocarcinoma and to abort ALPPS in patients who develop an interstage increase in bilirubin, due to the high risk of liver failure and mortality.
BACKGROUND: Posthepatectomy liver failure is one of the most feared complications in extended hepatic resections. In 2012, a novel two-stage liver resection was developed, able to induce rapid and extensive hypertrophy by portal vein ligation and in situ liver splitting - Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS). The technique became more widely employed but its use remained controversial due to reporting of high complication and mortality rates. METHOD: A national audit was performed to gather information about the safety of the procedure and to better understand the complications. The audit was offered to all high-volume hepatobiliary centers in Italy. RESULTS: Of all Italian centers approached in January 2012, 12 centers with experience in ALPPS enrolled and participated in collection of data. Fifty patients underwent ALPPS between 2012 and 2014. In 48/50 patients completion of hepatectomy was performed successfully. Major morbidity occurred in 54% with a 20% 90-day mortality. Uni- and multivariate analysis showed that ALPPS for cholangiocarcinoma and a peak of bilirubin over 5 mg/dl between stages was associated with increase of 90-day mortality and worse survival. DISCUSSION: It is proposed that a moratorium be introduced for classic ALPPS in cholangiocarcinoma and to abort ALPPS in patients who develop an interstage increase in bilirubin, due to the high risk of liver failure and mortality.
Authors: J Melendez; E Ferri; M Zwillman; M Fischer; R DeMatteo; D Leung; W Jarnagin; Y Fong; L H Blumgart Journal: J Am Coll Surg Date: 2001-01 Impact factor: 6.113
Authors: Kasia P Cieslak; Jurgen H Runge; Michal Heger; Jaap Stoker; Roelof J Bennink; Thomas M van Gulik Journal: Dig Surg Date: 2014-10-14 Impact factor: 2.588
Authors: Jun Li; Alexandros Kantas; Harald Ittrich; Andreas Koops; Eike G Achilles; Lutz Fischer; Bjoern Nashan Journal: Ann Surg Date: 2016-01 Impact factor: 12.969
Authors: Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt Journal: Ann Surg Date: 2012-03 Impact factor: 12.969
Authors: Erik Schadde; Dimitri Aristotle Raptis; Andreas A Schnitzbauer; Victoria Ardiles; Christoph Tschuor; Mickaël Lesurtel; Eddie K Abdalla; Roberto Hernandez-Alejandro; Elio Jovine; Marcel Machado; Massimo Malago; Ricardo Robles-Campos; Henrik Petrowsky; Eduardo De Santibanes; Pierre-Alain Clavien Journal: Ann Surg Date: 2015-11 Impact factor: 12.969
Authors: Juan Glinka; Victoria Ardiles; Juan Pekolj; Eduardo de Santibañes; Martin de Santibañes Journal: Hepatobiliary Surg Nutr Date: 2020-12 Impact factor: 7.293
Authors: Giovanni Vennarecci; Daniele Ferraro; Antonella Tudisco; Giovanni Battista Levi Sandri; Nicola Guglielmo; Giammauro Berardi; Isabella Sperduti; Giuseppe Maria Ettorre Journal: Updates Surg Date: 2018-09-25